← BackBrowse analysis archive →
Amgen's Repatha Cuts Death Risk in Patients at High Risk for First Heart Attack or Stroke
PRNewsWire · 74d ago · Sentiment +0.55
Read original ↗Impact scope
1 industry
direct 1·2nd-order 3
Top gainer
🔒
Top loser
🔒
Impact chainNews → industry → company, ranked top-down by impact
Pro only
Impact chains, crowding, market view and insider signals — try Pro free for 7 days when you sign up.
Start my free trial